Marcelo Souza de Andrade

Prof. Dr. Marcelo Souza de Andrade

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 July 2018 in Frontiers in Microbiology
Verified
Journal Article
Open access
PDF file
GSGiselle C. de Oliveira Santos
Giselle C. de Oliveira Santos
CVCleydlenne Costa Vasconcelos
Cleydlenne Costa Vasconcelos
ALBERTO JORGE OLIVEIRA LOPESALBERTO JORGE OLIVEIRA LOPES
ALBERTO JORGE OLIVEIRA LOPES
MCMaria Do S. de Sousa Cartágenes
Maria Do S. de Sousa Cartágenes
AFAllan K. D. B. Filho
Allan K. D. B. Filho
Cristina de Andrade MonteiroCristina de Andrade Monteiro
Cristina de Andrade Monteiro
The Candida genus comprises opportunistic fungi that can become pathogenic when the immune system of the host fails. Candida albicans is the most important and prevalent species. Polyenes, fluoropyrimidines, echinocandins, and azoles are used as commercial antifungal agents to treat candidiasis. However, the presence of intrinsic and developed resistance against azole antifungals has been extensively documented among several Candida species. The advent of original and re-emergence of classical fungal diseases have occurred as a consequence of the development of the antifungal resistance phenomenon. In this way, the development of new satisfactory therapy for fungal diseases persists as a major challenge of present-day medicine. The design of original drugs from traditional medicines provides new promises in the modern clinic. The urgent need includes the development of alternative drugs that are more efficient and tolerant than those traditional already in use. The identification of new substances with potential antifungal effect at low concentrations or in combination is also a possibility. The present review briefly examines the infections caused by Candida species and focuses on the mechanisms of action associated with the traditional agents used to treat those infections, as well as the current understanding of the molecular basis of resistance development in these fungal species. In addition, this review describes some of the promising alternative molecules and/or substances that could be used as anticandidal agents, their mechanisms of action, and their use in combination with traditional drugs.

11 August 2023 in Cancers
Verified
Journal Article
Open access
PDF file
LSLeandro Lima da Silva
Leandro Lima da Silva
ATAmanda Mara Teles
Amanda Mara Teles
Joana SantosJoana Santos
Joana Santos
MAMarcelo Souza de Andrade
Marcelo Souza de Andrade
Rui MedeirosRui Medeiros
Rui Medeiros
Rui M. Gil da CostaRui M. Gil da Costa
Rui M. Gil da Costa
High-risk human papillomavirus (HPV) is etiologically related to cervical cancer, other anogenital cancers and oropharyngeal carcinomas. Low-risk HPV, especially HPV6 and HPV11, cause genital warts and laryngeal papillomas. However, the accumulating data suggests that HPV6 and HPV11 may cause malignant lesions at non-cervical anatomic sites. This review aims to estimate the proportions of single and dual HPV6/11 infections in multiple cancers reported in the last 10 years in the Cochrane, Embasa and PubMed databases. Secondly, the genomes of HPV6/11 were compared with the most common high-risk genotype, HPV16, to determine the similarities and differences. A total of 11 articles were selected, including between one and 334 HPV+ cancer patients. The frequencies of single or dual HPV6/11 infections ranged between 0–5.5% for penile and 0–87.5% for laryngeal cancers and were null for vulvar, vaginal and oral cancers. The genomic similarities between HPV6/11 and HPV16 mainly involved the E7 gene, indicating a limited ability to block cell differentiation. The presence of single or dual HPV6/11 infections in variable proportions of penile and laryngeal cancers support the vaccination strategies that cover these genotypes, not only for preventing genital warts but also for cancer prevention. Other risk factors and co-carcinogens are likely to participate in epithelial carcinogenesis associated with low-risk HPV.

1 September 2016 in Cytokine
Verified
Journal Article
Closed access
CMConsuelo Penha Castro Marques
Consuelo Penha Castro Marques
EVElis Cabral Victor
Elis Cabral Victor
MFMayra Moura Franco
Mayra Moura Franco
JFJosé Mauro Carneiro Fernandes
José Mauro Carneiro Fernandes
YMYehoshua Maor
Yehoshua Maor
BBBruno Braga Benatti
Bruno Braga Benatti

5 November 2015 in Clinical and Experimental Immunology
Verified
Journal Article
Open access
PDF file
CMC P C Marques
C P C Marques
YMY Maor
Y Maor
MAMarcelo Souza de Andrade
Marcelo Souza de Andrade
Vandilson RodriguesVandilson Rodrigues
Vandilson Rodrigues
BBB B Benatti
B B Benatti
Summary: Toll-like receptors (TLRs) participate in the innate immune response and trigger the immune responses of the body. Systemic lupus erythematosus (SLE) is an autoimmune disease of unknown aetiology, characterized by an excessive autoimmune response in the body affecting the connective tissues. The disease is possibly triggered by both environmental aetiological factors and pathological organic processes such as exposure to sunlight, chronic infectious processes and genetic factors. Conversely, periodontal disease is an infectious disease caused by microorganisms in the oral cavity, resulting in a chronic inflammatory process which continuously stimulates the immune response, thus causing damage to the periodontal tissues. The expression of both TLR-2 and TLR-4 receptors are increased in both SLE and periodontal disease. Periodontitis might trigger excessive activation of immune response occurring in SLE by maintaining a high expression of TLRs, leading in turn to the acceleration of the onset and progression of autoimmune reactions. In addition, periodontal treatment is able to reduce the expression of these receptors and therefore the symptoms of SLE. Here we discuss the possible interaction between SLE and periodontitis, and suggest further studies evaluating common features in both factors that could explored, due to morbidity and mortality of SLE and the high incidence of periodontal infections around the world.

31 October 2023 in Diagnostics
Verified
Journal Article
Open access
PDF file
JMJucileide Mota
Jucileide Mota
ALAlice Marques Moreira Lima
Alice Marques Moreira Lima
JGJhessica I. S. Gomes
Jhessica I. S. Gomes
MAMarcelo Souza de Andrade
Marcelo Souza de Andrade
Haissa Oliveira BritoHaissa Oliveira Brito
Haissa Oliveira Brito
Rui M. Gil da CostaRui M. Gil da Costa
Rui M. Gil da Costa
Klotho proteins, αKlotho, βKlotho, and γKlotho, exert tumor-suppressive activities via the fibroblast growth factor receptors and multiple cell-signaling pathways. There is a growing interest in Klotho proteins as potential diagnostic and prognostic biomarkers for multiple diseases. However, recent advances regarding their roles and potential applications in cancer remain disperse and require an integrated analysis. The present review analyzed research articles published between 2012 and 2022 in the Cochrane and Scopus scientific databases to study the role of Klotho in cancer and their potential as tools for diagnosing specific cancer types, predicting tumor aggressiveness and prognosis. Twenty-six articles were selected, dealing with acute myeloid leukemia and with bladder, breast, colorectal, esophageal, gastric, hepatocellular, ovarian, pancreatic, prostatic, pulmonary, renal, and thyroid cancers. αKlotho was consistently associated with improved prognosis and may be useful in estimating patient survival. A single study reported the use of soluble αKlotho levels in blood serum as a tool to aid the diagnosis of esophageal cancer. γKlotho was associated with increased aggressiveness of bladder, breast, and prostate cancer, and βKlotho showed mixed results. Further clinical development of Klotho-based assays will require careful identification of specific tumor subtypes where Klotho proteins may be most valuable as diagnostic or prognostic tools.

15 February 2025 in Molecular and Cellular Biochemistry
Verified
Journal Article
Closed access
RMRaphael Furtado Marques
Raphael Furtado Marques
MAMarcelo Souza de Andrade
Marcelo Souza de Andrade
AFAndressa Coelho Ferreira
Andressa Coelho Ferreira
CDCarlos José Moraes Dias
Carlos José Moraes Dias
NJNivaldo de Jesus Silva Soares Junior
Nivaldo de Jesus Silva Soares Junior
RRRachel Melo Ribeiro
Rachel Melo Ribeiro